LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo

Pancreatic cancer is the leading cause of cancer death worldwide with a poor survival rate. The objective of this study was to determine the mechanism of action of a novel antimitotic and Stat3 inhibitor, LTP-1, on human pancreatic cancer in vitro and in vivo. We found that LTP-1 inhibited pancreati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Han-Li, Chao, Min-Wu, Chen, Chung-Chun, Cheng, Chun-Chun, Chen, Mei-Chuan, Lin, Chao-Feng, Liou, Jing-Ping, Teng, Che-Ming, Pan, Shiow-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899784/
https://www.ncbi.nlm.nih.gov/pubmed/27278358
http://dx.doi.org/10.1038/srep27794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899784/
https://www.ncbi.nlm.nih.gov/pubmed/27278358
http://dx.doi.org/10.1038/srep27794

Ejemplares similares